The excellent research on breath analysis lead by Prof. Dr. Malcolm Kohler and his team at USZ will now have an even higher throughput.

scienceexhalion
Written By Guest User

For this, statistical and biological relevance are essential.

With two EXHALION + Super SESI + Orbitrap Q-Exactive Plus platforms running in parallel, they will have the capacity to analyze thousands of patients. High-quality data with statistical significance.

Prof. Dr. Malcolm Kohler doubles down on Super SESI. It is an important validation for us. We are incredibly proud of being able to serve science!

Guillermo Vidal (FIT’s CEO) is at the laboratory of Prof. Dr. Kohler (USZ) during EXHALION and SUPER SESI second units.

Guillermo Vidal (FIT’s CEO) is at the laboratory of Prof. Dr. Kohler (USZ) during EXHALION and SUPER SESI second units.

Guest User
Previous

Personalized drug dosage with breath analysis demonstrated in a clinical setting
Next

You can now use the SimpleLINK UNO-16 even simpler!